ViewRay Inc's stock had its IPO on April 1, 2016, making it an older stock than just 15.21% of US equities in our set.
Revenue growth over the past 12 months for ViewRay Inc comes in at -25.88%, a number that bests merely 8.79% of the US stocks we're tracking.
ViewRay Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -31.63%, greater than the shareholder yield of only 12.84% of stocks in our set.
Stocks with similar financial metrics, market capitalization, and price volatility to ViewRay Inc are ONVO, REFR, CSOD, LLNW, and EGHT.
ViewRay, Inc. designs, manufactures, and markets radiation therapy systems worldwide. It offers MRIdian, a MRI-guided radiation therapy system that images and treats cancer patients simultaneously. MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. The company markets its MRIdian through a direct sales force in the United States and distributors worldwide to a range of customers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. was founded in 2004 and is based in Oakwood Village, Ohio.
CLEVELAND, July 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, July 30, 2020 at 4:30 p.m. ET / 1:30 p.m. PT. The dial-in…
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]